approved

Приложение 4 на ПЛС от 02.09.2019 г.

Unique identificator:  1b2fb502-1864-49cb-8754-bf8d6a3c8537

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-09-03 10:33:17
  • Created by: georgi_sivchev
  • Updated at: 2019-09-03 10:33:17
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1586.37 317.27 1903.64 4% 10 1596.37 319.27 1915.64 16% 25 1621.37 324.27 1945.64 НСР-8676/06.04.2016.; НСР-10996/24.11.2016 10.12.2016 02.01.2017 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3173.49 634.7 3808.19 4% 10 3183.49 636.7 3820.19 16% 25 3208.49 641.7 3850.19 НСР-8242/22.02.2016; НСР-10756/27.10.2016 11.11.2016 02.12.2016 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1597.44 319.49 1916.93 4% 10 1607.44 321.49 1928.93 16% 25 1632.44 326.49 1958.93 НСР-8676/06.04.2016. 22.04.2016 22.04.2016 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3232.65 646.53 3879.18 4% 10 3242.65 648.53 3891.18 16% 25 3267.65 653.53 3921.18 НСР-8242/22.02.2016 09.03.2016 09.03.2016 Неактивен 3232
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3232.73 646.55 3879.28 4% 10 3242.73 648.55 3891.28 16% 25 3267.73 653.55 3921.28 промяна обстоятелства НСР-6992/24.08.2015 НСР-6410/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 Novartis Europharm Limited, Обединено Кралство GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1601.71 320.34 1922.05 4% 10 1611.71 322.34 1934.05 16% 25 1636.71 327.34 1964.05 промяна обстоятелства НСР-6993/24.08.2015 НСР-5575/05.02.2015. 19.02.2015 19.02.2015 Неактивен 3568
Eltrombopag EU/1/10/ 612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations), UK 3376.96 675.39 4052.35 4% 10 3386.96 677.39 4064.35 16% 25 3411.96 682.39 4094.35 НСР-4739/02.10.2014 16.10.2014 16.10.2014 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1716.1 343.22 2059.32 4% 10 1726.1 345.22 2071.32 16% 25 1751.1 350.22 2101.32 НСР-3591/23.05.2014 06.06.2014 06.06.2014 Неактивен 3568
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1723.26 344.65 2067.91 4% 10 1733.26 346.65 2079.91 16% 25 1758.26 351.65 2109.91 НСР-857/09.08.2013 02.09.2013 02.09.2013 Неактивен 3568
Eltrombopag EU/1/10/612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 3446.56 689.31 4135.87 4% 10 3456.56 691.31 4147.87 16% 25 3481.56 696.31 4177.87 HCР-306/28.06.2013. 17.07.2013 17.07.2013 Неактивен 3232
Eltrombopag EU/1/10/612/005 REVOLADE, Film coated tablet, 50, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 3833.43 766.69 4600.12 4% 10 3843.43 768.69 4612.12 16% 25 3868.43 773.69 4642.12 КЦ-1683/25.06.2010 15.07.2010 15.07.2010 Неактивен 3232
Eltrombopag EU/1/10/612/002 REVOLADE, Film coated tablet, 25, mg, Pack: 28 GlaxoSmithKline Trading Services Limited, Ирландия GlaxoOperation UK Ltd.(trading as Glaxo Wellcome Operations) , UK 1916.71 383.34 2300.05 4% 10 1926.71 385.34 2312.05 16% 25 1951.71 390.34 2342.05 КЦ-1683/25.06.2010 15.07.2010 15.07.2010 Неактивен 3568
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol- Myers Squibb S.R.L., Italy 650.06 130.01 780.07 4% 10 660.06 132.01 792.07 16% 25 685.06 137.01 822.07 Отхвърлена жалба от Комисия по прозрачност с решение КП-95/06.04.2015; промяна обстоятелства НСР-9177/27.04.2016 НСР-4658/25.09.2014.; НСР-15690/17.05.2018 02.05.2015 02.06.2018 Заличен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol- Myers Squibb S.R.L., Italy 650.06 130.01 780.07 4% 10 660.06 132.01 792.07 16% 25 685.06 137.01 822.07 Отхвърлена жалба от Комисия по прозрачност с решение КП-95/06.04.2015; промяна обстоятелства НСР-9177/27.04.2016 НСР-4658/25.09.2014. 02.05.2015 02.05.2015 Неактивен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb, Rue du Docteur André Gilles, Epernon F-28230, France; Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France 650.06 130.01 780.07 4% 10 660.06 132.01 792.07 16% 25 685.06 137.01 822.07 Отхвърлена жалба от Комисия по прозрачност с решение КП-95/06.04.2015 НСР-4658/25.09.2014. 02.05.2015 02.05.2015 Неактивен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb, Rue du Docteur André Gilles, Epernon F-28230, France; Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France 657 131.4 788.4 4% 10 667 133.4 800.4 16% 25 692 138.4 830.4 Отхвърлена жалба от Комисия по прозрачност с решение КП-14/17.02.2015 НСР-3056/21.03.2014 16.03.2015 16.03.2015 Неактивен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb, Rue du Docteur André Gilles, Epernon F-28230, France; Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France 667.76 133.55 801.31 4% 10 677.76 135.55 813.31 16% 25 702.76 140.55 843.31 НСР-107/07.06.2013 03.07.2013 03.07.2013 Неактивен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb, Rue du Docteur André Gilles, Epernon F-28230, France; Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France 676.74 135.35 812.09 4% 10 686.74 137.35 824.09 16% 25 711.74 142.35 854.09 КЦРР-806/15.06.2012 07.08.2012 07.08.2012 Неактивен 3755
Atazanavir EU/1/03/267/004 REYATAZ, Capsule, hard, 150, mg, Pack: 60 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb, Rue du Docteur André Gilles, Epernon F-28230, France; Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, 19250 Meymac, France 736.27 147.25 883.52 6% 15 751.27 150.25 901.52 18% 30 781.27 156.25 937.52 КЦ-682/06.03.2009 23.03.2009 23.03.2009 Неактивен 3755
Atazanavir EU/1/03/26 7/008 REYATAZ, Capsule, hard, 300, mg, Pack: 30 Bristol-Myers Squibb Pharma EEIG, Обединено Кралство Bristol-Myers Squibb S.r.l., Италия 609.79 121.96 731.75 4% 10 619.79 123.96 743.75 16% 25 644.79 128.96 773.75 НСР-14499/23.11.2017 08.12.2017 02.01.2018 Активен 15940
Darunavir, Cobicistat EU/1/14/967/001 Rezolsta, Film coated tablet, 800 mg/150 mg, -, Pack: 30 Janssen-Cilag International N.V., Белгия Janssen-Cilag SpA, Италия 742.61 148.52 891.13 4% 10 752.61 150.52 903.13 16% 25 777.61 155.52 933.13 НСР-13622/01.09.2017; НСР-15564/04.05.2018; НСР-17668/02.01.2019 17.01.2019 02.02.2019 Активен 15835
Darunavir, Cobicistat EU/1/14/967/001 Rezolsta, Film coated tablet, 800 mg/150 mg, -, Pack: 30 Janssen-Cilag International N.V., Белгия Janssen-Cilag SpA, Италия 743.45 148.69 892.14 4% 10 753.45 150.69 904.14 16% 25 778.45 155.69 934.14 НСР-13622/01.09.2017; НСР-15564/04.05.2018 19.05.2018 02.06.2018 Неактивен 15835
Darunavir, Cobicistat EU/1/14/967/001 Rezolsta, Film coated tablet, 800 mg/150 mg, -, Pack: 30 Janssen-Cilag International N.V., Белгия Janssen-Cilag SpA, Италия 748.63 149.73 898.36 4% 10 758.63 151.73 910.36 16% 25 783.63 156.73 940.36 НСР-13622/01.09.2017 16.09.2017 02.10.2017 Неактивен 15835
Ribavirin EU/1/09/527/008 Ribavirin Teva Pharma B.V., Film coated tablet, 200, mg, Pack: 168 Teva Pharma B.V., Нидерландия TEVA Pharmaceutical Works Private Limited Company -Hungary;TEVA UK Ltd, UK; Pharmachemie BV - The Netherlands; Teva Sante S.A. - France; Teva Pharma SLU, Spain 460.52 92.1 552.62 4% 10 470.52 94.1 564.62 16% 25 495.52 99.1 594.62 Цената е заличена с решение НСР-2966/07.03.2014 НСР-1073/02.09.2013 17.09.2013 17.09.2013 Заличен 2087
Ribavirin EU/1/09/527/008 Ribavirin Teva Pharma B.V., Film coated tablet, 200, mg, Pack: 168 Teva Pharma B.V., Нидерландия Pharmachemie BV - The Netherlands; TEVA Pharmaceutical Works Private Limited Company -Hungary; TEVA UK Ltd, UK; Teva Sante S.A. - France 490.8 98.16 588.96 4% 10 500.8 100.16 600.96 16% 25 525.8 105.16 630.96 КЦРР-2119/28.01.2013 г 13.02.2013 13.02.2013 Неактивен 2087
Showing 11826 to 11851 of 15886 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте